Skeletal status of men with early and late ankylosing spondylitis

Y. S Lynda Lee, Tammi Schlotzhauer, Susan M. Ott, Ronald F. Van Vollenhoven, John C Hunter, Jay Shapiro, Robert Marcus, James L. McGuire

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

PURPOSE: To assess the influence of extent of disease on the skeletal status of men with ankylosing spondylitis (AS). PATIENTS AND METHODS: Fourteen men with AS were studied at entry and again after 15 months. Bone mineral density (BMD) was assessed by single photon absorptiometry (SPA), dual energy x-ray absorptiometry (DXA), and quantitative computed tomography (QCT). Calciotropic hormones and bone turnover were also assessed, and biopsies of lilac crest and skin were taken after tetracycline double- labeling from 10 subjects. Clinical evaluation and Health Assessment Questionnaires were used to assess functional status. RESULTS: Of the 14 participants, 7 had sacroiliitis alone without radiologic evidence of spinal involvement (early disease) and 7 had sacroiliitis with extensive vertebral calcifications and immobilization (late disease). QCT baseline lumbar spine BMD was very low in both groups compared with normative standards (Z score = -3.08 ± 1.83, P <0.0001) and did not change significantly over 15 months. This low BMD was more marked in late disease than in early disease subjects (P <0.01). DXA BMD at the lumbar spine was lower than predicted in early disease subjects (Z score = -1.08 ± 0.67, P = 0.005) but not in the late disease group. DXA BMD was also low at the all three hip sites (Z score = - 0.96 ± 0.86, P <0.01). Significant differences between late disease group and normative values were apparent at all hip sites. Values in early disease subjects, however, did not differ from age-predicted norms. Bone mineral status did not change significantly over the 15-month period of observation. Circulating parathyroid hormone (PTH) and vitamin D metabolites were normal in both groups as were creatinine clearance and urinary excretion of calcium and hydroxyproline. Osteocalcin levels were normal in all but the two youngest subjects in the early disease group. Histomorphometry of the lilac crest showed no consistent change in bone turnover. Bone volume and trabecular width were low in many cases. Cancellous bone volume correlated with lumbar spine BMD by QCT (r = 0.69, P = 0.026) but not with DXA. Although beneficial changes occurred in exercise tolerance and pain over time, anthropometric measurements did not improve. CONCLUSION: BMD is low in both the axial and peripheral skeleton in men with AS and is independent of spinal immobilization. Anterioposterior lumbar spine DXA in late AS is less useful than QCT in determining the degree of osteopenia in late AS. Bone mineral deficits in AS do not reflect measurable metabolic derangement or hypogonadism. Although bone histomorphometry suggests both trabecular thinning and loss of structural elements as mechanisms involved in low bone volume, the exact cause of osteopenia in AS remains to be determined.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalAmerican Journal of Medicine
Volume103
Issue number3
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Ankylosing Spondylitis
Bone Density
X-Rays
Spine
Tomography
Sacroiliitis
Bone and Bones
Bone Remodeling
Metabolic Bone Diseases
Immobilization
Minerals
Hip
Exercise Tolerance
Hypogonadism
Hydroxyproline
Osteocalcin
Photon Absorptiometry
Tetracycline
Parathyroid Hormone
Skeleton

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Lee, Y. S. L., Schlotzhauer, T., Ott, S. M., Van Vollenhoven, R. F., Hunter, J. C., Shapiro, J., ... McGuire, J. L. (1997). Skeletal status of men with early and late ankylosing spondylitis. American Journal of Medicine, 103(3), 233-241. https://doi.org/10.1016/S0002-9343(97)00143-5

Skeletal status of men with early and late ankylosing spondylitis. / Lee, Y. S Lynda; Schlotzhauer, Tammi; Ott, Susan M.; Van Vollenhoven, Ronald F.; Hunter, John C; Shapiro, Jay; Marcus, Robert; McGuire, James L.

In: American Journal of Medicine, Vol. 103, No. 3, 09.1997, p. 233-241.

Research output: Contribution to journalArticle

Lee, YSL, Schlotzhauer, T, Ott, SM, Van Vollenhoven, RF, Hunter, JC, Shapiro, J, Marcus, R & McGuire, JL 1997, 'Skeletal status of men with early and late ankylosing spondylitis', American Journal of Medicine, vol. 103, no. 3, pp. 233-241. https://doi.org/10.1016/S0002-9343(97)00143-5
Lee, Y. S Lynda ; Schlotzhauer, Tammi ; Ott, Susan M. ; Van Vollenhoven, Ronald F. ; Hunter, John C ; Shapiro, Jay ; Marcus, Robert ; McGuire, James L. / Skeletal status of men with early and late ankylosing spondylitis. In: American Journal of Medicine. 1997 ; Vol. 103, No. 3. pp. 233-241.
@article{b5651a9736ea4952aaeb1af6c05a8cec,
title = "Skeletal status of men with early and late ankylosing spondylitis",
abstract = "PURPOSE: To assess the influence of extent of disease on the skeletal status of men with ankylosing spondylitis (AS). PATIENTS AND METHODS: Fourteen men with AS were studied at entry and again after 15 months. Bone mineral density (BMD) was assessed by single photon absorptiometry (SPA), dual energy x-ray absorptiometry (DXA), and quantitative computed tomography (QCT). Calciotropic hormones and bone turnover were also assessed, and biopsies of lilac crest and skin were taken after tetracycline double- labeling from 10 subjects. Clinical evaluation and Health Assessment Questionnaires were used to assess functional status. RESULTS: Of the 14 participants, 7 had sacroiliitis alone without radiologic evidence of spinal involvement (early disease) and 7 had sacroiliitis with extensive vertebral calcifications and immobilization (late disease). QCT baseline lumbar spine BMD was very low in both groups compared with normative standards (Z score = -3.08 ± 1.83, P <0.0001) and did not change significantly over 15 months. This low BMD was more marked in late disease than in early disease subjects (P <0.01). DXA BMD at the lumbar spine was lower than predicted in early disease subjects (Z score = -1.08 ± 0.67, P = 0.005) but not in the late disease group. DXA BMD was also low at the all three hip sites (Z score = - 0.96 ± 0.86, P <0.01). Significant differences between late disease group and normative values were apparent at all hip sites. Values in early disease subjects, however, did not differ from age-predicted norms. Bone mineral status did not change significantly over the 15-month period of observation. Circulating parathyroid hormone (PTH) and vitamin D metabolites were normal in both groups as were creatinine clearance and urinary excretion of calcium and hydroxyproline. Osteocalcin levels were normal in all but the two youngest subjects in the early disease group. Histomorphometry of the lilac crest showed no consistent change in bone turnover. Bone volume and trabecular width were low in many cases. Cancellous bone volume correlated with lumbar spine BMD by QCT (r = 0.69, P = 0.026) but not with DXA. Although beneficial changes occurred in exercise tolerance and pain over time, anthropometric measurements did not improve. CONCLUSION: BMD is low in both the axial and peripheral skeleton in men with AS and is independent of spinal immobilization. Anterioposterior lumbar spine DXA in late AS is less useful than QCT in determining the degree of osteopenia in late AS. Bone mineral deficits in AS do not reflect measurable metabolic derangement or hypogonadism. Although bone histomorphometry suggests both trabecular thinning and loss of structural elements as mechanisms involved in low bone volume, the exact cause of osteopenia in AS remains to be determined.",
author = "Lee, {Y. S Lynda} and Tammi Schlotzhauer and Ott, {Susan M.} and {Van Vollenhoven}, {Ronald F.} and Hunter, {John C} and Jay Shapiro and Robert Marcus and McGuire, {James L.}",
year = "1997",
month = "9",
doi = "10.1016/S0002-9343(97)00143-5",
language = "English (US)",
volume = "103",
pages = "233--241",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Skeletal status of men with early and late ankylosing spondylitis

AU - Lee, Y. S Lynda

AU - Schlotzhauer, Tammi

AU - Ott, Susan M.

AU - Van Vollenhoven, Ronald F.

AU - Hunter, John C

AU - Shapiro, Jay

AU - Marcus, Robert

AU - McGuire, James L.

PY - 1997/9

Y1 - 1997/9

N2 - PURPOSE: To assess the influence of extent of disease on the skeletal status of men with ankylosing spondylitis (AS). PATIENTS AND METHODS: Fourteen men with AS were studied at entry and again after 15 months. Bone mineral density (BMD) was assessed by single photon absorptiometry (SPA), dual energy x-ray absorptiometry (DXA), and quantitative computed tomography (QCT). Calciotropic hormones and bone turnover were also assessed, and biopsies of lilac crest and skin were taken after tetracycline double- labeling from 10 subjects. Clinical evaluation and Health Assessment Questionnaires were used to assess functional status. RESULTS: Of the 14 participants, 7 had sacroiliitis alone without radiologic evidence of spinal involvement (early disease) and 7 had sacroiliitis with extensive vertebral calcifications and immobilization (late disease). QCT baseline lumbar spine BMD was very low in both groups compared with normative standards (Z score = -3.08 ± 1.83, P <0.0001) and did not change significantly over 15 months. This low BMD was more marked in late disease than in early disease subjects (P <0.01). DXA BMD at the lumbar spine was lower than predicted in early disease subjects (Z score = -1.08 ± 0.67, P = 0.005) but not in the late disease group. DXA BMD was also low at the all three hip sites (Z score = - 0.96 ± 0.86, P <0.01). Significant differences between late disease group and normative values were apparent at all hip sites. Values in early disease subjects, however, did not differ from age-predicted norms. Bone mineral status did not change significantly over the 15-month period of observation. Circulating parathyroid hormone (PTH) and vitamin D metabolites were normal in both groups as were creatinine clearance and urinary excretion of calcium and hydroxyproline. Osteocalcin levels were normal in all but the two youngest subjects in the early disease group. Histomorphometry of the lilac crest showed no consistent change in bone turnover. Bone volume and trabecular width were low in many cases. Cancellous bone volume correlated with lumbar spine BMD by QCT (r = 0.69, P = 0.026) but not with DXA. Although beneficial changes occurred in exercise tolerance and pain over time, anthropometric measurements did not improve. CONCLUSION: BMD is low in both the axial and peripheral skeleton in men with AS and is independent of spinal immobilization. Anterioposterior lumbar spine DXA in late AS is less useful than QCT in determining the degree of osteopenia in late AS. Bone mineral deficits in AS do not reflect measurable metabolic derangement or hypogonadism. Although bone histomorphometry suggests both trabecular thinning and loss of structural elements as mechanisms involved in low bone volume, the exact cause of osteopenia in AS remains to be determined.

AB - PURPOSE: To assess the influence of extent of disease on the skeletal status of men with ankylosing spondylitis (AS). PATIENTS AND METHODS: Fourteen men with AS were studied at entry and again after 15 months. Bone mineral density (BMD) was assessed by single photon absorptiometry (SPA), dual energy x-ray absorptiometry (DXA), and quantitative computed tomography (QCT). Calciotropic hormones and bone turnover were also assessed, and biopsies of lilac crest and skin were taken after tetracycline double- labeling from 10 subjects. Clinical evaluation and Health Assessment Questionnaires were used to assess functional status. RESULTS: Of the 14 participants, 7 had sacroiliitis alone without radiologic evidence of spinal involvement (early disease) and 7 had sacroiliitis with extensive vertebral calcifications and immobilization (late disease). QCT baseline lumbar spine BMD was very low in both groups compared with normative standards (Z score = -3.08 ± 1.83, P <0.0001) and did not change significantly over 15 months. This low BMD was more marked in late disease than in early disease subjects (P <0.01). DXA BMD at the lumbar spine was lower than predicted in early disease subjects (Z score = -1.08 ± 0.67, P = 0.005) but not in the late disease group. DXA BMD was also low at the all three hip sites (Z score = - 0.96 ± 0.86, P <0.01). Significant differences between late disease group and normative values were apparent at all hip sites. Values in early disease subjects, however, did not differ from age-predicted norms. Bone mineral status did not change significantly over the 15-month period of observation. Circulating parathyroid hormone (PTH) and vitamin D metabolites were normal in both groups as were creatinine clearance and urinary excretion of calcium and hydroxyproline. Osteocalcin levels were normal in all but the two youngest subjects in the early disease group. Histomorphometry of the lilac crest showed no consistent change in bone turnover. Bone volume and trabecular width were low in many cases. Cancellous bone volume correlated with lumbar spine BMD by QCT (r = 0.69, P = 0.026) but not with DXA. Although beneficial changes occurred in exercise tolerance and pain over time, anthropometric measurements did not improve. CONCLUSION: BMD is low in both the axial and peripheral skeleton in men with AS and is independent of spinal immobilization. Anterioposterior lumbar spine DXA in late AS is less useful than QCT in determining the degree of osteopenia in late AS. Bone mineral deficits in AS do not reflect measurable metabolic derangement or hypogonadism. Although bone histomorphometry suggests both trabecular thinning and loss of structural elements as mechanisms involved in low bone volume, the exact cause of osteopenia in AS remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0030767444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030767444&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(97)00143-5

DO - 10.1016/S0002-9343(97)00143-5

M3 - Article

C2 - 9316556

AN - SCOPUS:0030767444

VL - 103

SP - 233

EP - 241

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -